Key terms
About Lantheus Holdings, Inc. 2.625% 15-DEC-2027
Sector
Health Technology
Industry
Medical Specialties
Home page
FIGI
BBG01BWC8JB0
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Related bonds
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.